Nvidia Is Up 186% From A Year Ago, Yet These 7 Stocks Have More Than Doubled Their Returns Over The AI Chipmaker
Portfolio Pulse from Piero Cingari
NVIDIA Corp. (NASDAQ:NVDA) has seen a 186% surge in the past year, driven by high demand for AI chips, making it the third-largest U.S. company by market value. However, seven other U.S. stocks have more than doubled Nvidia's returns over the same period, including Vera Therapeutics, Vertiv Holdings, MicroStrategy, Abercrombie & Fitch, Carvana, Soleno Therapeutics, and MoneyLion.
May 29, 2024 | 9:56 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Abercrombie & Fitch's stock surged 503% due to successful rebranding, strong e-commerce growth, and improved profitability.
The company's successful rebranding, e-commerce growth, and improved profitability metrics have driven its stock price up.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 70
POSITIVE IMPACT
Carvana's stock skyrocketed 666% as the company recovered from a difficult period and investors regained confidence in its business model.
Carvana's recovery and renewed investor confidence in its unique business model have significantly boosted its stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 75
POSITIVE IMPACT
MoneyLion's stock surged 790% due to aggressive expansion and innovation in fintech services.
MoneyLion's aggressive expansion and innovation in fintech services have significantly boosted its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 80
POSITIVE IMPACT
MicroStrategy's stock rose 441%, closely tied to Bitcoin's price movements, which saw a 140% rise.
MicroStrategy's stock performance is closely linked to Bitcoin's price movements, which have seen a significant rise.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 75
POSITIVE IMPACT
NVIDIA Corp. has experienced a 186% increase in stock price over the past year due to high demand for AI chips, making it the third-largest U.S. company by market value.
NVIDIA's significant stock price increase is attributed to the growing demand for AI chips, which has driven its market value to $2.8 trillion.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Soleno Therapeutics' stock surged 697% due to positive clinical trial results and increased optimism about its drug pipeline.
Positive clinical trial results and increased optimism about Soleno Therapeutics' drug pipeline have driven its stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 80
POSITIVE IMPACT
Vera Therapeutics' stock surged 363% due to advancements in its clinical programs and optimistic projections for its drug candidates.
The stock price increase is driven by positive developments in Vera Therapeutics' clinical programs and future drug candidate projections.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 80
POSITIVE IMPACT
Vertiv Holdings' stock increased by 413% due to rising demand for data centers and IT infrastructure.
The demand for data centers and IT infrastructure has driven Vertiv Holdings' stock price up significantly.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 70